Rocket Pharmaceuticals Inc (RCKT)
23.35
+0.37
(+1.61%)
USD |
NASDAQ |
May 09, 16:00
23.34
0.00 (0.00%)
Pre-Market: 20:00
Rocket Pharmaceuticals Price to Book Value: 4.801 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 4.801 |
| May 08, 2024 | 4.725 |
| May 07, 2024 | 4.803 |
| May 06, 2024 | 4.770 |
| May 03, 2024 | 4.826 |
| May 02, 2024 | 4.682 |
| May 01, 2024 | 4.633 |
| April 30, 2024 | 4.423 |
| April 29, 2024 | 4.491 |
| April 26, 2024 | 4.518 |
| April 25, 2024 | 4.543 |
| April 24, 2024 | 4.857 |
| April 23, 2024 | 4.865 |
| April 22, 2024 | 4.906 |
| April 19, 2024 | 4.686 |
| April 18, 2024 | 4.826 |
| April 17, 2024 | 4.867 |
| April 16, 2024 | 4.984 |
| April 15, 2024 | 4.930 |
| April 12, 2024 | 4.966 |
| April 11, 2024 | 5.190 |
| April 10, 2024 | 5.014 |
| April 09, 2024 | 5.205 |
| April 08, 2024 | 5.008 |
| April 05, 2024 | 5.135 |
| Date | Value |
|---|---|
| April 04, 2024 | 5.129 |
| April 03, 2024 | 5.221 |
| April 02, 2024 | 5.277 |
| April 01, 2024 | 5.486 |
| March 28, 2024 | 4.950 |
| March 27, 2024 | 5.007 |
| March 26, 2024 | 4.880 |
| March 25, 2024 | 4.942 |
| March 22, 2024 | 5.000 |
| March 21, 2024 | 5.091 |
| March 20, 2024 | 5.119 |
| March 19, 2024 | 4.937 |
| March 18, 2024 | 4.873 |
| March 15, 2024 | 4.926 |
| March 14, 2024 | 5.012 |
| March 13, 2024 | 5.174 |
| March 12, 2024 | 4.972 |
| March 11, 2024 | 5.071 |
| March 08, 2024 | 5.121 |
| March 07, 2024 | 5.056 |
| March 06, 2024 | 5.102 |
| March 05, 2024 | 5.062 |
| March 04, 2024 | 5.275 |
| March 01, 2024 | 5.610 |
| February 29, 2024 | 5.384 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.255
Minimum
May 11 2022
14.78
Maximum
Dec 22 2020
4.122
Average
3.794
Median
Nov 27 2023
Price to Book Value Benchmarks
| ADMA Biologics Inc | 11.70 |
| Geron Corp | 6.690 |
| Madrigal Pharmaceuticals Inc | 5.189 |
| Ligand Pharmaceuticals Inc | 1.918 |
| Puma Biotechnology Inc | 4.532 |
Price to Book Value Related Metrics
| Price | 23.35 |
| Earnings Yield | -12.29% |
| Market Cap | 2.120B |